Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects.
Xie J, Fan X, Su Y, Zhou H, Cao S, Zhu X, Zhu M, He C, Wang Y, Fan L, Ge Q, Zhu J, Liu B, Chen X, Xie Y, Ma L, Liu Y, Chen J, Wang H, Li Z. Xie J, et al. Among authors: ge q. Clin Pharmacol Drug Dev. 2022 Nov;11(11):1273-1283. doi: 10.1002/cpdd.1136. Epub 2022 Jul 17. Clin Pharmacol Drug Dev. 2022. PMID: 35844038 Free PMC article. Clinical Trial.
A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers.
Zhou H, Cao S, Zhu X, Xie J, Fan L, Ge Q, Wang Y, Zhu J, Liu Y, Shao Z, Shan R, Liu B, Wang H, Ding L. Zhou H, et al. Among authors: ge q. Expert Opin Drug Metab Toxicol. 2020 Oct;16(10):997-1003. doi: 10.1080/17425255.2020.1807935. Epub 2020 Aug 26. Expert Opin Drug Metab Toxicol. 2020. PMID: 32847423 Free article. Clinical Trial.
Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone® in healthy Chinese male volunteers.
Zhou H, Xie J, Zhu X, Li X, Yu X, Zhang Y, Su Y, He C, Zhu M, Li XL, Liu Y, Chen J, Cheng D, Chen M, Wang Y, Ge Q, Fan L, Wang Y, Shao Z, Liu B, Shan R, Dai X, Wang H, Wang H. Zhou H, et al. Among authors: ge q. Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1149-1156. doi: 10.1080/17425255.2021.1948534. Epub 2021 Aug 10. Expert Opin Drug Metab Toxicol. 2021. PMID: 34372746 Free article. Clinical Trial.
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [14C] SHC014748M in healthy Chinese subjects following oral administration.
Guo F, Liu B, Li X, Wang H, Zhu X, Su Y, He C, Zhu M, Ding J, Xu Y, Zhao X, Wang Y, Shan R, Zhu J, Xie J, Ge Q, Fan L, Ding Y, Xie Y, Zhang C, Li H, Wang H, Zhou H. Guo F, et al. Among authors: ge q. Cancer Chemother Pharmacol. 2023 Feb;91(2):143-156. doi: 10.1007/s00280-022-04493-5. Epub 2022 Dec 27. Cancer Chemother Pharmacol. 2023. PMID: 36572783
Evaluation of bioequivalence and safety analysis of capecitabine tablets and Xeloda® under postprandial dosing conditions in Chinese patients with solid tumor.
Li H, Shan R, Ding J, Zhang J, Liu B, Ge Q, Cheng D, Li L, Zhang C, Su H, Li X, Li H, Ye J, Li H, Li F, Zhou H, Huo Q, Su Y. Li H, et al. Among authors: ge q. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):1015-1021. doi: 10.1080/17425255.2023.2292735. Epub 2024 Jan 12. Expert Opin Drug Metab Toxicol. 2023. PMID: 38059472 Free article. Clinical Trial.
1,755 results